The present studies sought to define the impact of tau aggregate accumulation in brain microvascular endothelial cells on vascular function and were designed to test the hypothesis that soluble tau aggregates enter brain microvascular endothelial cells and trigger pathogenic processes leading to microvascular deficits of AD. The gene discussed is MAPT; the disease is Alzheimer disease.